Prostate Cancer, Low Risk
Low-risk prostate cancer is typically slow-growing and confined to the prostate gland. It is defined by a PSA level under 10 ng/mL, a Gleason score of 6 (Grade Group 1), and clinical stage T1-T2a. Many men with low-risk disease may never develop symptoms or need aggressive treatment. Because of its favorable prognosis, active surveillance is often the preferred initial approach, especially for older patients or those with other health issues. This strategy involves regular monitoring with PSA tests, imaging, and repeat biopsies.
AI Summary of Treatment Experiences
Not medical advice.
Low-risk prostate cancer is typically slow-growing and confined to the prostate gland. It is defined by a PSA level under 10 ng/mL, a Gleason score of 6 (Grade Group 1), and clinical stage T1-T2a. Many men with low-risk disease may never develop symptoms or need aggressive treatment. Because of its favorable prognosis, active surveillance is often the preferred initial approach,…
Treatments Shared by the Community
Explore what patients, caregivers, and clinicians have said about these treatments.
4 Treatments for Prostate Cancer, Low Risk
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.